GHIT Fund accelerates promising efforts to find new treatments, vaccines and diagnostics

(Burness) The Global Health Innovative Technology (GHIT) Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced US$16.7 million to support development of new compounds for fighting malaria and tuberculosis, a leishmaniasis vaccine and drug, and a treatment for a long-ignored flesh-eating infection. The new investments also will allow scientists to pursue a critically needed diagnostic tool for detecting a relapsing form of malaria when it is hiding in the liver during its dormant phase.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news